NEURAXPHARM PHARMACEUTICALS, S.L
ItalyAll drugs from this manufacturer
-
Briumvi is used for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), characterized by attacks of symptoms followed by periods of improvement or absence of symptoms.
Dosage form: solution for infusion, concentrate
Active substance Dosage ublituximab - ATC: L04AG14
-
It is used to stop a sudden and prolonged seizure in children and adults who have been diagnosed with epilepsy.
Dosage form: solution, oral mucosa
Active substance Dosage midazolam hydrochloride - ATC: N05CD08
-
It is used to treat opioid (narcotic) dependence in adults and adolescents over 15 years of age who are also receiving medical, social, and psychological support. It helps prevent withdrawal symptoms and reduce drug cravings.
Dosage form: film, sublingual
Active substance Dosage buprenorphine - ATC: N07BC01
-
It is used for the treatment of relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older.
Dosage form: capsules, hard gelatin, gastro-resistant
Active substance Dosage dimethyl fumarate - ATC: L04AX07
-
It is used as maintenance treatment for the symptoms of schizophrenia in adults who have already been stabilized with paliperidone or risperidone.
Dosage form: suspension for injection, prolonged-release in pre-filled syringe
Active substance Dosage paliperidone - ATC: N05AX13
-
It is used for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years, when stimulant medications are unsuitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine - ATC: C02AC02
-
It is prescribed to adults suffering from narcolepsy to help them stay awake and reduce the likelihood of sudden sleep attacks during the day.
Dosage form: tablets
Active substance Dosage modafinil - ATC: N06BA07
-
RIULVY is used to treat relapsing-remitting multiple sclerosis (RRMS) in patients aged 13 years and older.
Dosage form: capsules, hard gelatin, gastro-resistant
Active substance Dosage tegomil fumarate - ATC: L04AX10
-
It is used for the treatment of children and adolescents between 6 and 18 years of age with attention deficit hyperactivity disorder (ADHD), in combination with psychological, educational, and social therapy programs.
Dosage form: tablets, chewable, prolonged-release
Active substance Dosage methylphenidate - ATC: N06BA04